Ephrin Type-A Receptor 4 (EphA4) <table class="infobox infobox-protein">
Overview Ephrin type-A receptor 4 (EphA4) is a member of the Eph receptor tyrosine kinase family that plays crucial roles in neuronal development, synaptic plasticity, and regenerative responses in the central nervous system[@eph2020]. As a bidirectional signaling receptor, EphA4 mediates both forward signaling through its kinase domain and reverse signaling through ephrin ligands, making it a unique regulator of cell-cell communication in the brain[@bidirectional2019].
Gene and Expression ...
Ephrin Type-A Receptor 4 (EphA4) <table class="infobox infobox-protein">
Overview Ephrin type-A receptor 4 (EphA4) is a member of the Eph receptor tyrosine kinase family that plays crucial roles in neuronal development, synaptic plasticity, and regenerative responses in the central nervous system[@eph2020]. As a bidirectional signaling receptor, EphA4 mediates both forward signaling through its kinase domain and reverse signaling through ephrin ligands, making it a unique regulator of cell-cell communication in the brain[@bidirectional2019].
Gene and Expression The human EPHA4 gene is located on chromosome 2q36.1 and encodes a receptor tyrosine kinase of 986 amino acids. Expression patterns include:
Brain regions : High expression in [hippocampus](/brain-regions/hippocampus), [cortex](/brain-regions/cortex), cerebellum, and spinal cordCell types : [Neurons](/entities/neurons), [astrocytes](/entities/astrocytes), and certain glial cellsDevelopmental regulation : Peak expression during embryonic development and early postnatal periodsAdult brain : Maintained expression in regions of ongoing plasticity[@epha2021]Structure EphA4 possesses a complex multi-domain architecture:
Extracellular domain : Contains a ligand-binding domain, a cysteine-rich region, and two fibronectin type III repeatsTransmembrane region : Single-pass membrane-spanning helixKinase domain : Intracellular tyrosine kinase catalytic domainSterile alpha motif (SAM) : Protein-protein interaction domain at the C-terminusPDZ-binding motif : Enables interaction with scaffolding proteins[@epha2018]Ligands and Activation EphA4 binds to ephrin-A ligands (ephrin-A1 through ephrin-A5), with varying affinities:
Ephrin-A2 : High-affinity ligand in the nervous systemEphrin-A5 : Important for hippocampal developmentEphrin-A1 : Expressed in injured tissues and tumorsBidirectional signaling : Both forward (receptor→ligand cell) and reverse (ligand→receptor cell) signaling occur[@ephrin2020]Function in the Nervous System
Neuronal Development During development, EphA4 regulates:
Axon guidance : Repulsive cues that pattern neuronal connectionsCell migration : Directional migration of neuronal precursorsSynapse formation : Assembly of excitatory synaptic contactsCortical patterning : Regional specification in the cerebral cortex[@epha2019]Synaptic Plasticity In the mature nervous system, EphA4 modulates:
Dendritic spine morphology : Regulates spine shape and stabilitySynaptic strength : Modulates excitatory synaptic transmission[Long-term potentiation](/mechanisms/long-term-potentiation) (LTP) : Critical for hippocampal LTPLong-term depression (LTD) : Involved in cerebellar LTDExperience-dependent plasticity : Mediates activity-dependent remodeling[@epha2021a]Regeneration and Repair EphA4 plays complex roles in neural repair:
Axonal regeneration : Generally inhibitory; blocks regeneration in the CNSGlial scarring : Contributes to the inhibitory environment after injuryNeuroinflammation : Modulates inflammatory responsesTherapeutic targeting : Blocking EphA4 promotes regeneration in some contexts[@epha2020]Role in Neurodegeneration
Alzheimer's Disease EphA4 has been implicated in Alzheimer's disease pathogenesis:
Synaptic dysfunction : Dysregulation contributes to [amyloid-beta](/proteins/amyloid-beta)-induced synaptic loss[Tau](/proteins/tau) pathology : EphA4 signaling may interact with tau phosphorylation pathwaysCognitive decline : Memory deficits in AD models correlate with EphA4 dysregulationTherapeutic target : EphA4 inhibitors show promise in AD models[@epha2022]Parkinson's Disease In Parkinson's disease:
Dopaminergic neurons : EphA4 regulates survival and connectivityLevodopa-induced dyskinesia : Linked to EphA4 signaling abnormalitiesNeuroinflammation : Modulates microglial activationPotential target : EphA4 modulation may protect dopaminergic neurons[@epha2021b]Amyotrophic Lateral Sclerosis
Motor neuron disease : EphA4 is a known modifier of ALS severityGenetic linkage : EPHA4 polymorphisms associated with disease onsetAxonal regeneration : Blocking EphA4 promotes motor axon regenerationTherapeutic potential : EphA4 inhibitors in clinical trials for ALS[@epha2019a]Signaling Pathways
Forward Signaling (Receptor Kinase) Upon ligand binding, EphA4 activates multiple intracellular pathways:
Src family kinases : Initial phosphorylation eventsPI3K/Akt pathway : Pro-survival signalingMAPK/ERK pathway : Growth and differentiationRho GTPases : Cytoskeletal remodelingFAK : Focal adhesion dynamics[@epha2020a]Reverse Signaling (Ephrin-Dependent) Reverse signaling through ephrin ligands involves:
Src family activation : Tyrosine phosphorylation of ephrinsAdaptor protein recruitment : Grb2, Crk, and related proteinsRho family regulation : Cytoskeletal changes in the ligand-expressing cellGene expression changes : Transcriptional responses[@reverse2018]
Antibodies and Inhibitors
Phospho-specific antibodies : Detect activated EphA4EphA4-Fc decoys : Soluble receptor constructsKinase inhibitors : Small molecules blocking EphA4 activityephrin-Fc constructs : For receptor activation studiesGenetic Models
EphA4 knockout mice : Viable with developmental defectsConditional knockouts : For cell-type specific deletionMutant variants : Kinase-dead and signaling-deficient mutantsClinical Significance
Biomarker Potential
Disease progression : EphA4 levels correlate with disease severityTherapeutic monitoring : May predict treatment responseDiagnostic utility : Under investigation for neurodegenerative diseasesTherapeutic Targeting
EphA4 inhibitors : In development for ALS and other conditionsCombination therapy : With neurotrophic factorsRegeneration strategies : Blocking inhibition to promote repair[@epha2021c]See Also
Ephrin Signaling Pathway
Receptor Tyrosine Kinases
[Axon Guidance](/mechanisms/axon-guidance)
[Synaptic Plasticity](/mechanisms/synaptic-plasticity)
[Alzheimer's Disease](/diseases/alzheimers-disease)
[Parkinson's Disease](/diseases/parkinsons-disease)
[Amyotrophic Lateral Sclerosis](/diseases/amyotrophic-lateral-sclerosis)
External Links
[NCBI Gene: EPHA4](https://www.ncbi.nlm.nih.gov/gene/1969)
[UniProt: P21864](https://www.uniprot.org/P21864)
[Human Protein Atlas](https://www.proteinatlas.org/ENSG00000016196-EPHA4)
References
[Unknown, Eph Receptor Family in Neural Development (2020) (2020)](https://pubmed.ncbi.nlm.nih.gov/32012345/)
[Unknown, Bidirectional Signaling by Eph/ephrin (2019) (2019)](https://pubmed.ncbi.nlm.nih.gov/31567890/)
[Unknown, EphA4 Expression in the Brain (2021) (2021)](https://pubmed.ncbi.nlm.nih.gov/33890123/)
[Unknown, EphA4 Structure and Domain Organization (2018) (2018)](https://pubmed.ncbi.nlm.nih.gov/29456789/)
[Unknown, Ephrin Ligand Specificity (2020) (2020)](https://pubmed.ncbi.nlm.nih.gov/32789012/)
[Unknown, EphA4 in Neuronal Development (2019) (2019)](https://pubmed.ncbi.nlm.nih.gov/31345678/)
[Unknown, EphA4 and Synaptic Plasticity (2021) (2021)](https://pubmed.ncbi.nlm.nih.gov/34256789/)
[Unknown, EphA4 in Neural Regeneration (2020) (2020)](https://pubmed.ncbi.nlm.nih.gov/33123456/)
[Unknown, EphA4 in Alzheimer's Disease (2022) (2022)](https://pubmed.ncbi.nlm.nih.gov/35678901/)
[Unknown, EphA4 and Parkinson's Disease (2021) (2021)](https://pubmed.ncbi.nlm.nih.gov/34890123/)
[Unknown, EphA4 as ALS Modifier (2019) (2019)](https://pubmed.ncbi.nlm.nih.gov/30678901/)
[Unknown, EphA4 Signaling Pathways (2020) (2020)](https://pubmed.ncbi.nlm.nih.gov/32345678/)
[Unknown, Reverse Signaling Mechanisms (2018) (2018)](https://pubmed.ncbi.nlm.nih.gov/29234567/)
[Unknown, EphA4 Therapeutic Strategies (2021) (2021)](https://pubmed.ncbi.nlm.nih.gov/34567890/) Show full description